These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38421436)

  • 1. The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.
    Xu Q; Sang Y; Gao A; Li L
    Eur J Clin Pharmacol; 2024 Jun; 80(6):785-795. PubMed ID: 38421436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.
    Rao GG; Konicki R; Cattaneo D; Alffenaar JW; Marriott DJE; Neely M;
    Ther Drug Monit; 2020 Feb; 42(1):83-92. PubMed ID: 31652190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
    Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
    Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review.
    Villa G; Di Maggio P; De Gaudio AR; Novelli A; Antoniotti R; Fiaccadori E; Adembri C
    Crit Care; 2016 Nov; 20(1):374. PubMed ID: 27863531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
    Douros A; Grabowski K; Stahlmann R
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1849-59. PubMed ID: 26457865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant
    Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK
    Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
    Cojutti P; Maximova N; Crichiutti G; Isola M; Pea F
    J Antimicrob Chemother; 2015 Jan; 70(1):198-206. PubMed ID: 25182066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.
    Hendershot PE; Antal EJ; Welshman IR; Batts DH; Hopkins NK
    J Clin Pharmacol; 2001 May; 41(5):563-72. PubMed ID: 11361053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.
    Cattaneo D; Alffenaar JW; Neely M
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):533-44. PubMed ID: 26982718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
    Yotsu RR; Richardson M; Ishii N
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012118. PubMed ID: 30136733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
    Stalker DJ; Jungbluth GL
    Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug Interactions.
    Töpper C; Steinbach CL; Dorn C; Kratzer A; Wicha SG; Schleibinger M; Liebchen U; Kees F; Salzberger B; Kees MG
    Ther Drug Monit; 2016 Oct; 38(5):573-8. PubMed ID: 27631464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic evaluation of concomitant administration of linezolid and aztreonam.
    Sisson TL; Jungbluth GL; Hopkins NK
    J Clin Pharmacol; 1999 Dec; 39(12):1277-82. PubMed ID: 10586394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid pharmacokinetics: a systematic review for the best clinical practice.
    Heidari S; Khalili H
    Eur J Clin Pharmacol; 2023 Feb; 79(2):195-206. PubMed ID: 36565357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of linezolid in critically ill patients.
    Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic and adrenergic drug interactions associated with linezolid: a critical review and practical management approach.
    Ramsey TD; Lau TT; Ensom MH
    Ann Pharmacother; 2013 Apr; 47(4):543-60. PubMed ID: 23548646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
    Bock M; Van Hasselt JGC; Schwartz F; Wang H; Høiby N; Fuursted K; Ihlemann N; Gill S; Christiansen U; Bruun NE; Elming H; Povlsen JA; Køber L; Høfsten DE; Fosbøl EL; Pries-Heje MM; Christensen JJ; Rosenvinge FS; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Iversen K; Bundgaard H; Moser C
    J Antimicrob Chemother; 2023 Dec; 78(12):2840-2848. PubMed ID: 37823408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.